Montara Therapeutics, Inc. — Form D

Montara Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-13. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-03-13
• Form: D
• Accession: 0002008775-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $20.0M
• Amount sold: $20.0M
• Investors: 9
• Date of first sale: 2025-02-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-540767

Issuer

• Name: Montara Therapeutics, Inc.
• CIK: 0002008775
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 135 MISSISSIPPI STREET, SAN FRANCISCO, CA, 94107
• Phone: 310-463-6172

Officers, directors & promoters (10)

Other filings by this issuer (1)

More

• CIK 2008775 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search